Parallel Advisors’s AngioDynamics ANGO Stock Holding History

Parallel Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-72	Closed	-$526	–	3321
2023 Q3	$526	Hold	72	–	–	﹤0.01%	3097
2023 Q2	$751	Buy	72 +17	+31%	+$164	﹤0.01%	3002
2023 Q1	$569	Sell	55 -70	-56%	-$896	﹤0.01%	3080
2022 Q4	$1.72K	Buy	125 +32	+34%	+$445	﹤0.01%	2740
2022 Q3	$2K	Hold	93	–	–	﹤0.01%	2580
2022 Q2	$2K	Hold	93	–	–	﹤0.01%	2529
2022 Q1	$2K	Sell	93 -57	-38%	-$1.29K	﹤0.01%	2541
2021 Q4	$4K	Hold	150	–	–	﹤0.01%	2453
2021 Q3	$4K	Hold	150	–	–	﹤0.01%	2426
2021 Q2	$4K	Hold	150	–	–	﹤0.01%	2342
2021 Q1	$4K	Hold	150	–	–	﹤0.01%	2237
2020 Q4	$2K	Hold	150	–	–	﹤0.01%	2263
2020 Q3	$2K	Hold	150	–	–	﹤0.01%	2264
2020 Q2	$1K	Hold	150	–	–	﹤0.01%	2284
2020 Q1	$1K	Buy	+150	New	+$1.88K	﹤0.01%	2225

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Parallel Advisors's ANGO Position: Q4 2023 in Review

Parallel Advisors sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 72 shares — an estimated $526 sold.

Parallel Advisors first reported a position in ANGO in Q1 2020 and held it in 15 quarters. The position peaked at $4K in Q4 2021. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

Parallel Advisors reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
Parallel Advisors sold 72 AngioDynamics shares in Q4 2023, an estimated $526.
Parallel Advisors first reported a position in AngioDynamics in Q1 2020 and held it in 15 quarters.
Parallel Advisors's AngioDynamics position peaked at $4K in Q4 2021.
150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.